Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 10, 2002, Pages 4470-4475

  Rogers, A ^a,c   Saleh, G ^b   Hannon, R A ^a   Greenfield, D ^a   Eastell, R ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

^c NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; ESTRADIOL; OSTEOPROTEGERIN;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MINERAL; BONE TURNOVER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTRADIOL BLOOD LEVEL; FEMALE; FEMUR NECK; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OSSIFICATION; OSTEOLYSIS; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; URINE LEVEL;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BODY MASS INDEX; BONE DENSITY; BONE REMODELING; ESTRADIOL; FEMALE; FEMUR; GLYCOPROTEINS; HUMANS; LUMBAR VERTEBRAE; MIDDLE AGED; OSTEOPROTEGERIN; POSTMENOPAUSE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; REGRESSION ANALYSIS;

RODENTIA;

EID: 0036775538     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-020396     Document Type: Article

References (23)

1. , Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD 2000 Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: The OFELY study. J Bone Miner Res 15:1526-1536
2. Chapurlat RD, Garnero P, Breart G, Meunier PJ, Delmas PD 2000 Serum estradiol and sex hormone-binding globulin and the risk of hip fracture in elderly women: The EPIDOS study. J Bone Miner Res 15:1835-1841
3. Chapurlat RD, Bauer DC, Cummings SR 2001 Association between endogenous hormones and sex hormone-binding globulin and bone turnover in older women: Study of osteoporotic fractures. Bone 29:381-387
4. Pacifici R 1998 Cytokines, estrogen, and postmenopausal osteoporosis - The second decade. Endocrinology 139:2659-2661
5. Rogers A, Eastell R 1998 Effects of estrogen therapy of postmenopausal women on cytokines measured in peripheral blood. J Bone Miner Res 13:1577-1586
6. Rogers A, Eastell R 2001 The effect of 17β-estradiol on production of cytokines in cultures of peripheral blood. Bone 29:30-34
7. Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Spelsberg TC, Riggs BL 1999 Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology 140:4367-4370
8. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Boyle WJ 1997 Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89:309-319
9. Tsuda E, Goto M, Mochizuki S, Yano K, Kobayashi F, Morinaga T, Higashio K 1997 Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun 234:137-142
10. Mizuno A, Amizuka N, Irie K, Murakami A, Fujise N, Kanno T, Sato Y, Nakagawa N, Yasuda H, Mochizuki S, Gomibuchi T, Yano K, Shima N, Washida N, Tsuda E, Morinaga T, Higashio K, Ozawa H 1998 Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. Biochem Biophys Res Commun 247:610-615
11. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T 1998 Osteoclast differentiation factor is a ligand for osteoprotegerin /osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:3597-3602
12. Deleted in proof.
13. Yano K, Tsuda E, Washida N, Kobayashi F, Goto M, Harada A, Ikeda K, Higashio K, Yamada Y 1999 Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: Increased serum concentrations in postmenopausal women with osteoporosis. J Bone Miner Res 14:518-527
14. Fraher LJ, Watson PH, Kisiel M, Natale BV, Hodsman AB 2000 Measurement of circulating osteoprotegerin (OPG) in human sera: Inhibition of circulating OPG in osteoporotic patients treated with hPTH (1-34). J Bone Miner Res 15(Suppl 1):S441
15. Bekker PJ, Holloway D, Nakanishi A, Arrighi M, Leese PT, Dunstan CR 2001 The effect of a single dose of osteoprotegerin in postmenopausal women. J Bone Miner Res 16:348-360
16. Cooper C, O'Neill T, Silman A 1993 The epidemiology of vertebral fractures. European vertebral osteoporosis study group. Bone 14(Suppl 1):S89-S97
17. Hannon R, Blumsohn A, Naylor K, Eastell R 1998 Response of biochemical markers of bone turnover to hormone replacement therapy: Impact of biological variability. J Bone Miner Res 13:1124-1133
18. Browner WS, Lui LY, Cummings SR 2001 Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women. J Clin Endocrinol Metab 86:631-637
19. Szulc P, Hofbauer LC, Heufelder AE, Roth S, Delmas PD 2001 Osteoprotegerin serum levels in men: Correlation with age, estrogen, and testosterone status. J Clin Endocrinol Metab 86:3162-3165
20. Arrighi H, Khosla S, Melton LJ, Riggs BL, Bekker PJ, Dunstan CR 2000 The relationship between circulating osteoprotegerin and estrogen in postmenopausal women. J Bone Miner Res 15(Suppl 1):S441
21. Hofbauer LC, Heufelder AE 2001 Role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in bone cell biology. J Mol Med 79:243-253
22. Kostenuik PJ, Shalhoub V 2001 Osteoprotegerin: A physiological and pharmacological inhibitor of bone resorption. Curr Pharm Des 7:613-635
23. Chen D, Sarikaya NA, Gunn H, Martin SW, Young JD 2001 ELISA methodology for detection of modified osteoprotegerin in clinical studies. Clin Chem 47:747-749